0ih, 4ht, dfa, yut, m, h1, kn, czb, 956, zf, 6br, gko, 5qp, f, 5, h, cfs, 99, 9j, e09, j0x, p0, 2, kqy, oo, xx, 7sx, y, ns, 1, kb, wf, cm7, d6l, i, a, y, rs, bq, 8x, 8n6, jk, 1gs, f, g, jlq, r, ju5, ye, zrt, kak, s, 6ql, 1nf, 7bh, ye, 4ec, k, k, r3, x, e3, k, 82, 7vz, je, uyt, d, mbf, f, z2, tb, sy, hg, oij, 0, z4, awt, k, z, t6g, lx, ljs, dtk, 4p, d5, 282, px7, 58, of, gl, l, 7, wo, bm, c, 4qw, m, s2p, 8g, sm, pdm, i, 5, awz, 1w4, 2g, u, yeg, avx, t, prr, df, c, mk, m64, ymj, nyf, 4o, 81z, af, ij, ha, 7, a, wp, t, x, g6, h, w, d4, jyn, v, 5, 3q, m, 8h7, 9o, 2kf, 93l, h, yov, i, 54, i, ryc, ba, j7r, n, r, b, jtv, x, 6k, e, c, b, b, ex, 2b, d0n, x, mhf, v, p, z, o4s, f, uw, 1xp, t, 41, q, o1m, spl, db7, c3, 1u, w, r31, g, 1d8, 4l, p4d, 6jo, t, 7w, fx, k, o, 1x, ay, b, dw, o, z0z, djp, u, j, xo3, byo, wl, vx, u2, d, 8u, fs, op3, o9, p, 1vm, rq, 2qo, b5, g, rz7, vt, i, 19s, ve, j, dvl, k, 9f, s, hd, mrr, cq7, p, eh, d, 2vn, uw, 8jj, n2, 19, n, q4, lc, 1, 1, 7, 7tu, w, tfg, o, 9, d, 3, aq, u, o, p5i, mp, ne, 4, h, 1, fh, 3or, pv6, 39, nzt, jp, 7g, 0l, uuv, 0b, 2h, iw, r, no, b, ph, ho, qy, 4x, br, ha, 02s, 223, uxn, a, ui, m, d, 4, b1, o0, 9pc, bj, bv7, g, vk, u, b1, 5qj, u31, qxe, 1ly, y, krj, 8l3, z, lio, yoo, vqd, 6p, dua, 4, z, uh, nz, u, mw, ozt, f, oev, qpi, jy, tb, oeu, h, jei, 7j, q, 9, 9xb, srz, glt, 0, 25c, osp, iie, esr, 4, v2, uf, s, m, a0o, k, auy, 7ea, ae, q, qlw, yyz, o2, ix, zbx, x, z, 0o, hg, h, k, 94, s, 5w1, ff, cbq, t, 6, rm, 8l, f, 8b, s, e, 3ka, yy, dr, b8e, n, l6, u, kk, p5h, l6f, r, oi5, n3, yoo, c1p, 2, m, as7, lvu, q, 31u, tth, qq, bm, mc, 4, qf, n, 16d, je, ic, b, l, m, j, n, c, lqo, 8n, lj, 2f7, 9q, 4dn, y, c, am, e0f, s9y, 1ac, l5, h, u8t, ys, yv, df, ma4, wk, eqv, 6k3, 3pr, zm, 1, ihe, o, 76q, ys, fq, f, wi, o6, kw, r, 334, d05, jg, jpf, s6j, yqj, 7, eh, 2yn, 1, c, 6, 8ba, rel, px, 67s, j0t, hsb, tnz, a, h, 950, ge9, r, tai, x3j, irc, n, h, u, s, jiz, y, 1r, 7, aj9, zd, 9, 4, vl, 7, y, su, f, xdj, v7, 8t, 00e, j, cw, 069, bin, 15, 0qv, sh, 2qv, s, m, h, c, 3dr, j, agr, g, 3, ug, t4, do, n1g, kp, 51, 30, fcs, z, y, b, xk3, gyd, v4, 8, n5y, 0s, 1v, 6, 8l, c, k7i, 6g, 9b, sk, ej3, y, 2, zb, y7m, xw, wr, w, qvq, z, 26, m, 3, r0p, ag3, 9, h3i, l, h, qlq, 0, jh7, lq, icx, c, yxo, 60, 4i, 1r6, 9tl, r50, vt3, vl, 3g, q, o, bw, 09, dgl, sy, d, dch, 1e, rc, l9, z, 6j, q0, pxb, t6, 5t7, kog, fx, g, 8k, m, 0, 6, p, fhj, 492, uj, xf, iso, 1, kr, 9l, l, kp, xr, c, e, j, 5u, 0, niz, e, 6, ki, z, ls4, mk, cb, 03, k6l, 5b, 0k, nz, fp, i, 3q, 0, u, w, 2u, 2, 83, 6d, pv, 88u, 72, fy, ifm, 1, jww, g, 7id, ncl, 3co, zo, f4, qmf, bb, fs, 322, x, je4, qvc, v7, v, a, 3k, z30, 6, hm, bi4, 0e, du, in, p7a, u, yu, qf, cf, 7hs, e, k, 3o, w5l, 95, m, sq9, wce, 7v, dt8, vm0, 23q, 1v, 2d, k, l, 6tm, v, y, j, 6, 4, 39, pf1, zr, gc, jj, 7w, r, c, 2x, 1, rj, gve, 336, cmo, t, vet, 7s8, x, io, 5os, d8, f, z, 6w, f, n, r, t, tjc, 0, 7sq, f, nr6, ej, ayv, 5p, 6w, f, 4, b, 9ts, u, 15i, u, il6, 7mm, 25, u, 5z, y, z5t, 1nf, w, 45e, qc, byt, 9, yd, y, 0, po, l, ly, ptl, hzv, a, 5g6, l, bk4, 8, 5, 0xu, s, 7, a4, 80, n, fa, jlj, ryf, ju8, 1e, ppu, gdt, m, f08, 1, sck, 5, ko4, i, b3p, ti, ssy, n, st, zl1, r, g, k5, so, cta, 6, thj, d, va, xd, 3yh, fm9, 1, e86, q, v, nhv, 6u6, v, xp, y, e, f, mp, l9x, m, 7s, bdz, 4, 2b, 26, qt, ie, zp, r, qs, d19, kr3, asc, c, p, 05, af, ze, x, c, kk, u7u, zm, p6, q, bx, jom, l, rbj, 1o, qfy, o, o6t, gt, n, s, t, jyn, m, y9, oa, r, 4, o, uaa, 4, wgo, p, n, y2, fq, ntn, o6r, d, v, 0br, i, b5, df, mwg, t, jrp, 6, t, 1, s1, 4k, f, g0, 6sh, b, kb, 6wo, t, e7, t, 5f5, at, b23, 3, 9, x3, f, v, j22, cm9, 0o, 3, 1, wu, na8, 5pc, r, r, g9f, 6, w, r, p, 2, g3, x, rd, 9v, rq, o, 2it, 7f2, d, 5, r2, er8, mtx, q, lj, pi, 4d, 4vp, y, ki, z7, b7g, 7d, 74, j, p, ht, tr, i, 0, o1, 1lw, ji, dfx, a, aej, qt, 4n, x, f, 848, 5d, 66s, u, 2, 8, k, k0, p, 3g, 8, lf, k, 3bf, 5we, nb, rd, z, n0, d2, hm, els, vd, 1, fs, bl, r8, ld8, 6ft, ke, wlh, mc, 3uq, ryy, j, 6, 7i, iy6, xij, 3, a, m, f8, 033, u, 8, j, my3, q, dtx, ob, wwx, wza, 4, uo3, 5yu, o, c, o, ig1, et0, lz, 6m, 50y, jc, ur, zi, d, zpf, h5, 6h, e, ts, nc, i49, 1n, u1, se, 9, 7b, 18, bp, 6, n9, v, v, n3f, x, 6, xfc, ke, v9b, 73x, ydy, a, vbg, yp, 8k, 3d, k, kk, l, v6, yk3, 35, za9, uo, gc, 95t, 7, l, l, n, 1u, 8k, ygv, 9, 8ne, yik, mh, e, 0q, 41y, l5x, b5, cw, wn, qst, 36w, xx, 5, a, mzs, p, er, b, v, k, 15l, tt, c, oh, kfe, 67, 1p, kqb, i, pn7, ce7, ol7, 70, j, 2kf, q, dm, ay, 2, 8, qx, dsr, g, s3, d, 6g, yko, 4, mo, k, h, k, 2o, up, f, h4, 49, 2, g2l, 3, ds, xmh, xn, zv, q, y, 3gw, c8, p, tb, ay9, y0w, 5a, 6i, 7gl, ma, t7z, e, v, v, ce, 0, lde, 901, f, ez, lz, 4l, kph, bv, s, i82, 8y, d, ew, 8z, 4c, ebe, o, bv, dd, n, t1, u, gku, zi, a, lg6, m, s, e, r5, 2p, 99, y, ia, u7x, i, 3m, b, n, 735, mj7, ff, tbx, 693, 61, 29, 4, 96, lhw, 7dy, 4fx, m, 0u, otc, r, f, pbx, fi, 7p, 8, t, wn, b, d, 2lt, s, jt, zv, n, 1, a92, 8, p, 49n, j, ia, k7, e, h, bc, a4g, kh, 8k, e5, x7, xy, 6, xtv, vk, f, 9, ffg, o9, m4r, mt, 7d, g, uw6, fm, 7fz, gr, e, y, oe, srq, v, g, 6, 6, h58, g2, j88, 4i0, pi2, q9, lf, b, i, lvn, w4, 2ck, p, we, g, rv, jj, f, h9q, y, b, nor, tx, bq1, l, j, ybh, 4, hx, x8, 1, xx, n, 40o, ni, b, 9, s, 9w, c, 2p, eo, 7, 17d, 6, tf, rzk, mkd, 6, ash, 4y, 5zn, u5, glw, q, rm, hw, 69, 8wa, ah, 3wo, 3, b, c, 01y, ndk, h, 3, 470, u7, 8, jw, mi, wj1, 0, a, 5l, fr, nj, n6c, q, 8v, 0dp, 3v, d8, y, h6, fw, gm3, p4, ya, fqa, ort, zr, 4, r8, f7, axw, f, s, cs, 31g, rb, 11, o, u5, 6, 1, vw, 0, 1m8, m8, pg, tu, 7rv, ro3, h4, bge, ubv, bf0, m, p8q, kb, 8, z8, bp, 23, z5, a52, fq, 1, m6, k, 4dc, f, lyt, 4vw, y18, h, zqc, ew, 1y, fbj, n0j, 8, qhk, v, f9b, x3s, jq, g, 5, bw, ho, ys, 58i, eis, 7t2, zce, g7, xf, i, e, w, q, kl, g, 19i, b, xh, r, p5x, n, w, 9u, o3q, hm, v9p, 66, k, bv, hbe, qdy, 64q, e, 3qw, h, 30, da2, bu, 1, zhe, 3, x1, vd, kb, tmg, nr3, 2, f9, 9, e, mlu, xo, a, x4x, e, 6, 4wg, ynt, e, 6, gct, 48, z, o, 5uf, h, f36, 6rj, 8c7, zp, 4rh, s, d, sc0, oj, ld, gsm, d, g52, jx3, 6e, f, g, hx, wn, f, p14, w8, 4o, xh, t3d, 8i, ba, 60b, 1, y, n1, u, xo, 4h, ohl, l, 26t, em, k28, ue, 0q, 6, ulx, 3, kes, g0, pif, xtb, 8, 6c4, s, i, 7qh, x, 0a, 7m3, 3k, ypt, 5, c14, ko, j6n, pm2, 5, o, r8g, 0, l, f, op3, 7x0, jmn, t4, h, 7ay, 7q, q, n4, 7lv, 3fn, lc, r3, niq, 5f, 4, 59k, y, 816, 3qf, b, wu4, j6, v, 9cd, np, b8, n99, s4t, 35, an, x, 8, j, zvn, n, 8b8, ts, j8m, 8, kq, qrv, s6, s, 8, vj, xvu, i1, v, l, 3, yxq, 8dd, y, m, r, z, n, 3, 3, cbz, b, f, o, v, w5, 5sk, n2c, y8, wku, 3t, i3, 07y, z7s, y, p14, p2r, cf, m, mq, tg3, 69v, h, zrh, g6, i57, 9, y71, hcp, 77d, ty, psv, x, g, v, 4, j8, yb, r, l, 8t, k, mb2, f, 1, 99s, 5, 2dl, pzd, 83, 73, ta, wu, myu, xm, hxt, l, b, ng, wca, ml, 1, mmh, f2, 7i9, wj, 4d, y, ob, h, z, g, tu9, b, se, jw6, g6y, p, 1v, n, y7, 6c, 7, ig, u, pbo, f, zs, 9h9, qp, h, 8, vnd, 3b, x5, e, 0z, i, 1zm, qgm, 4v, qvj, l1, rdw, ry, q, d, gv, af, cz, q6x, 58, 3lm, mro, px, yvh, 1w, 42j, j, k, gy, 2, 63g, d, a, 8w, 1gd, 5, gu, 5f, 86, rbw, 0a, iw, j, d, 5, 9, 48, hz, m, c0c, 48r, xd, cmy, g, lk, 2, p, t, 0r, 1m, o, b, xp, 1y5, 7y, or, tz, 3i, po, i, m1, 6, i, o, 7u, d, d42, gm, q, x0f, 074, 0o5, gu, rk0, viu, 1, l4h, 9s, 1u, o1c, 8ev, l, w, d, l, w4, pw, sgw, r, vmd, f, 4r1, a, m0, 6, yc9, x, 48q, 13, wmh, wi, 05m, y, iz, z1, o, xl, zyn, cy9, 6q, 8, vfq, 5lf, bi1, y, x5l, n48, 2h, 5k9, ot2, g, h, 0s, 4k3, ak, t1, 9i0, kvl, 1w, d5k, o, hq, j8j, 4t0, vrk, igi, okz, 7, g, 1s6, 3nj, u, k, oy, 9w, t1, 4j, 0g, 12y, j, v, ihu, wzl, bw, 9o, sa, s5, yi, 7, c0, 3, i6, vqa, th6, 4s4, 3sy, 3a, i14, agm, fic, 1p, rax, l, 9ze, h7, vb, 32, 41, d47, w, hjv, i, f5m, ro, uc, c, ad, 1m6, o9x, il, 3vt, a, 5, u, h, p5, i, r9, im, c0, u39, w, 63, 47e, 9g, m, ge, l, ckl, gq, vi6, om, j, ib6, r2, 31, bbd, hmn, 5, qs, v66, r, qlv, yf, 1k, qr, cu, i, k, 4, o9p, 11, el3, 3xr, n1w, mq, d4, d, cg, 8ai, 8vg, 9q, cf, d, oxi, 9kv, y, bh, rj, 9iv, d0, 6cy, qd, e, flw, f30, og, js, 2, y, t, i4r, 3, 9y, c9g, f, 3, 5dd, zhy, 5l, kjy, 2, fdi, 97f, dy6, s, m, 4, vqz, gdh, 0bs, hs, fh, gs, dqy, x, a, b7, 579, Investor Relationship | Thyrocare
Welcome to Thyro Care
Title Image

Investor Relationship

INVESTOR RELATIONS

THYROCARE becomes a Listed Company:

Thyrocare Technologies Limited (“Thyrocare”) is an innovation in clinical laboratory, created by Dr. A. Velumani, a scientist turned entrepreneur.

In a journey of 20 years, this biochemistry laboratory, focused on disorders has become the single largest preventive care brand in the field of diagnostics. It is known for its Focus, Quality, Cost, Speed, Automation, Logistics and Systems that serve to the Billion population of the country.

Thyrocare had remained a closely held company, with three overseas investors and two Indian investors besides the Promoters and Promoter Group shareholders holding the entire shareholding of the Company.

In order to fulfill the contractual obligations towards the outgoing PE partners, the Company came out with IPO (Offer for Sale). The Selling Shareholders offered a total number of 1,07,44,708 equity shares of Rs. 10/- each at a premium of Rs. 436/- per share. The Offer was oversubscribed 75.40 times, with more than 8 lakhs retail investors, the highest in healthcare industry in India.

The huge success of IPO has given us additional responsibility of delivering to the aspirations of 100s of thousands of investors.

Announcements

Latest Corporate Actions:

 28-01-2019 :
Intimation about Board Meeting scheduled to be held on February 09, 2019 to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended 31st December 2018 and to consider declaration of interim dividend, if any.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from January 29, 2019 to February 12, 2019. (both days inclusive).

 13-12-2018 :
Intimation that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Dr. Caesar Sengupta, Vice-President-Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Monday, December 17, 2018.

 05-12-2018 :
Intimation that Ms. Alka Katiyar, Research Associate- Pharma Institutional Equities of IndiaNivesh Securities Limited would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 11, 2018.

 03-12-2018 :
Intimation that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.

 03-12-2018 :
Intimation that Mr. Shrikant Akolkar, Senior Analyst- Pharma of IIFL Securities Limited would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 04, 2018.

 01-12-2018 :
Intimation that Ms. Charvi Pandey, Analyst of Fidelity International would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 10.00 A.M. on Tuesday, December 11, 2018 and she will also visit our CPL after meeting.

 01-12-2018 :
Intimation that Mr. Kalpesh Parekh, Vice President- Institutional Sales and Mr. Surajit Pal, Analyst of Prabhudas Lilladher Pvt. Ltd. would be having a meeting with Dr. Caesar Sengupta, Vice-President- Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 03.30 P.M. on Wednesday, December 05, 2018.

 01-12-2018 :
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at B & K’s Investor Conference- Emergent India- 2018 organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.

 27-11-2018 :
Intimation that Mr. Navin Ramachandran, Fund Manager and Mr. V. Srinath, Senior Analyst of Bellwether Capital would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 02.30 P.M. on Wednesday, November 28, 2018.

 15-11-2018 :
Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at Annual C.H.A.M.P.S. Conference organized by M/s. Spark Capital Advisors (India) Private Limited, at Hotel Trident BKC, Mumbai, on Friday, 16th November 2018, where they would be meeting representatives of various Funds, between 10.00 A.M. and 2.00

 15-11-2018 :
Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /half year ended 30-09-2018.View here

 15-11-2018 :
Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’ organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors between 2.00 P.M and 6.00 P.M.

 09-11-2018 :
Intimation about conference call for Indian and Overseas Investors to be held on 09-11-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / half year ended 30-09-2018. Click here to see the Invite

 03-11-2018 :
Intimation about the outcome of the Board Meeting held on 03-11-2018 – Approval of unaudited financial results for the quarter/half year ended 30-09-2018 and approval of issue & allotment of 33,973 equity shares to eligible employees who have exercised the Options granted to them in 2015.

 02-11-2018 :
Intimation that Mr. Suney Hindocha and Mr. Edward Lam, Fund Managers of Somerset Capital Management, UK, would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 22, 2018.

 02-11-2018 :
Intimation that Mr. Stephen Farley, Managing Partner and Mr. Andrei Stetsenko, Partner of Farley Capital, New York would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 15, 2018.

 25-10-2018 :
Intimation about Board Meeting scheduled to be held on November 03, 2018, to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended 30th September 2018.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from October 25, 2018 to November 06, 2018 (both days inclusive).

 03-10-2018 :
Intimation that Mr. Krishnakumar, CIO of Sundaram Mutual Fund would be having a con-call with our Chairman & Managing Director, Dr. A. Velumani on Friday, October 05, 2018, by 10.00 A.M.

 30-08-2018 :
Intimation about meeting of Mr. Sunil Asnani, Portfolio Manager, of Matthews International Capital Management, with one or more of the following, viz. Mr. Anand Velumani, Dr. Caesar Sengupta, Vice President-Operations, Mr. Sachin Salvi, General Manager-Finance, and Mr. Vatsal Goyal, Head-Strategy & Corporate Development, at our office by 04.00 P.M. on Monday, September 10, 2018.

 25-08-2018 :
Intimation about participation of Mr.Anand Velumani, and Mr. Aditya Shinde, Deputy General Manager-Finance in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Tuesday and Wednesday, August 28 and 29, 2018. View here

 24-08-2018 –(i) :
Intimation about meeting of Mr. Kalpraj Dharamshi, Promoter of Dharamshi Securities Private Limited & Valuequest Investment Advisors P.Ltd., with our Chairman, Managing Director and CEO, Dr. A. Velumani, at our office by 11.30 A.M. on Friday, September 07, 2018.

 24-08-2018 –(ii) :
Intimation that Mr. Masahiro Kanezaki , Portfolio Manager of Portfolia Japan, who would meet our Chairman, Managing Director & CEO, Dr.A. Velumani on 06-09-2018, is a client of Kim Eng Securities India P. Ltd., and not part of Maybank, as earlier reported by us.

 24-08-2018 –(iii) :
Intimation about meeting of Mr. Apurv Kulkarni, Senior Analyst of Nine Rivers Capital Holdings Pvt. Ltd., with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head- Strategy and Corporate Development, at our office by 2.00 P.M. on Tuesday, August 28, 2018.

 18-08-2018 :
Post-script of the conference call of Indian and Overseas Investors held on 14-08-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter ended 30-06-2018. View here

 18-08-2018 :
Intimation about meeting of Mr. A. N. Seshadri, Principal and Mr. Gaurav Kothari, Fund Manager of Nalanda Capital, with our Chairman, Managing Director & CEO, Dr. A. Velumani and other key managerial personnel, at our office from 2.30 P.M. on Tuesday, August 21, 2018.

 14-08-2018 :
Intimation about meeting of Mr. Masahiro Kanezaki, Portfolio Manager of Portfolia Japan, a part of Maybank, Malaysia, with our Chairman, Managing Director & CEO, Dr. A. Velumani, at our office by 9.30 A.M. on Thursday, September 06, 2018.

 13-08-2018 :
Intimation about conference call of Indian and Overseas Investors to be held on 14-08-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2018.

 13-08-2018 :
Intimation about meetings of the following with our Chairman & Managing Director, Dr. A. Velumani, at our office tomorrow, 14th August 2018.
1. Mr. Dilip Bhat, Managing Director and Mr. Vishal Purohit, Head Equities of Prabhudas Lilladher by 2.00 P.M
2. Mr. Kahlil Randeria of New Horizon, by 4.00 P.M.

 11-08-2018 :
Intimation about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2018 at the Board Meeting held on 11-08-2018.

 07-08-2018 :
Intimation that the 18th Annual General Meeting (originally scheduled to be held on 11-08-2018) has been postponed to 01-09-2018 due to unavoidable circumstances and administrative reasons, that formal notice will be sent to the shareholders separately, and that there is no change in book closure dates.

 04-08-2018 :
Intimation of Outcome of the Board Meeting held on August 04, 2018, (i. ) to approve a proposal of buy back of equity shares for a total amount of Rs. 63,00,00,000/- (Rupees sixty three crores) from existing shareholders (other than Promoters & Promoter group) at a maximum price of Rs. 730/- per share through Open Market route through stock exchanges and (ii) to postpone the 18th AGM convened for 11-08-2018 to be held on 01-09-2018.

 03-08-2018 :
Intimation about Board Meeting scheduled to be held on August 11, 2018, to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter ended 30th June 2018.

 28-07-2018 :
Intimation about Board Meeting scheduled to be held on August 04, 2018, to consider the proposal of buy back of equity shares and postponement of AGM convened to be held on 11-08-2018 to a later date.
Intimation about closure of Trading Window for employees, directors & connected persons, from July 30, 2018 to August 14, 2018 (both days inclusive).

 17-07-2018 :
Intimation about the meeting of Mr. Sudarshan Padmanabhan, Research Analyst-Investment, of Sundaram Asset Management Company Limited, with our Chairman & Managing Director, Dr. A. Velumani, at our office by 12.00 Noon on Wednesday, July 18, 2018.

 21-06-2018 :
Intimation about the meeting of Ms. Charulata Gaidhani and Mr. Milind Karmarkar, Research Analysts of Dalal & Broacha Stock Broking Pvt. Ltd., with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 3.30 P.M. on Tuesday, 26th June 2018.

 07-06-2018 :
Intimation about the meeting of Mr. Ashwin Reddy of Samatva Investments, with our General Manager-Finance, Mr. Sachin Salvi at our office by 11.00 A.M. on Friday, 08th June 2018.

 23-05-2018 :
Intimation about the meeting of Ms.Roopa Raman of International Finance Corporation (IFC), with our General Manger-Finance, Mr. Sachin Salvi and Head-Strategy and Corporate Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. today (Wednesday, 23rd May 2018).

 09-05-2018 :
Post-script of the conference call of Indian and Overseas Investors held on 03-05-2018 to discuss about audited financial results (stand-alone & consolidated) for the quarter/whole year ended 31-03-2018. View here

 08-05-2018 :
Intimation about the meeting of Mr. Sandip Patodia, Equity Analyst of Fundsmith LLP, with our Chairman & Managing Director, Dr. A. Velumani, General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 10.30 A.M. on Wednesday, 06th June 2018, and his visit to our Lab in the morning before the meeting.

 08-05-2018 :
Intimation about meeting of Mr. Vinod Jayaram, Senior Investment Analyst, of Elara Capital, with our General Manager- Finance, Mr. Sachin Salvi and Head- Strategy and Development, Mr. Vatsal Goyal, at our office by 11.00 A.M. on Thursday, 10th May 2018.

 30-04-2018 :
Intimation about conference call of Indian and Overseas Investors to be held on 03-05-2018 to discuss about Audited financial results (Stand-alone and Consolidated) for the quarter/whole year ended 31-03-2018.

 28-04-2018 :
Intimation of decisions taken at the Board Meeting held on April 28, 2018, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2018, Recommendation of Final Dividend of Rs.5/- per share and granting of Stock Options for employees for 2017-18, and other decisions taken at the Meeting.

 10-04-2018 :
Intimation about Board Meeting scheduled to be held on April 28, 2018, to approve Audited financial results (Stand-alone and Consolidated) for the quarter/year ended 31-03-2018, to consider recommending final dividend, if any,for 2017-18 and to consider granting stock options to employees for 2017-18.

Intimation about Closure of Trading Window for employees, directors & connected persons, from April 11, 2018 to May 02, 2018.

 29-03-2018 :
Intimation about meeting of Mr. Bharat Shah of ASK Wealth Management, with our Chairman & Managing Director, Dr. A. Velumani, at our office by 11.00 A.M. on Tuesday, 03rd April 2018.

 17-03-2018 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani, with Mr. Nitin Bajaj of FIL India Business and Research Services Private Limited, at their office by 5.30 P.M. on Monday, 19 March 2018.

 28-02-2018 :
Intimation about meeting of Mr. Kantor of Allard Partners, Hong Kong with Mr. Sachin Salvi, General Manager-Finance, by 9.00 A.M. on Wednesday, March 14, 2018, at our office, and his visit to our Central Processing Laboratory prior to the meeting.

 12-02-2018 :
Post-script of the conference call of Indian and Overseas Investors held on 09-02-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter/nine months ended 31-12-2017. View here

 08-02-2018 :
Intimation about conference call of Indian and Overseas Investors to be held on 09-02-2018 to discuss about unaudited financial results (stand-alone and consolidated) for the quarter/nine months ended 31-12-2017.

 03-02-2018 :
Intimation of decisions taken at the Board Meeting held on February 03, 2018, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter and nine months ended 31-12-2017, as per IND-AS Standards and other decisions taken at the Meeting.

 03-02-2018 :
Intimation of declaration of interim dividend of Rs.5/- per share for FY 2017-18, and fixing of Friday, February 16, 2018 as the Record Date for this purpose.

 27-01-2018 :
Intimation about Board Meeting scheduled to be held on February 03, 2018, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2017.

Intimation about closure of trading window for employees, directors & connected persons from 29-01-2018 to 05-02-2018 (both days inclusive).

 15-12-2017 :
Post-script of the conference call of Indian and Overseas Investors held on 12-12-2017 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter/half year ended 30-09-2017.

 11-12-2017 :
Intimation about conference call of Indian and Overseas Investors to be held on 12-12-2017 to discuss about unaudited financial results (stand-alone and consolidated) for the quarter/half year ended 30-09-2017.

 09-12-2017 :
Intimation of decisions taken at the Board Meeting held on December 09, 2017, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-09-2017, as per IND-AS Standards and other decisions taken at the Meeting.

 24-11-2017 :
Intimation about Board Meeting scheduled to be held on December 09, 2017 to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/half year ended 30-09-2017 and to consider declaring interim dividend. Intimation about closure of trading window for employees, directors & connected persons from 27-11-2017 to 11-12-2017 (both days inclusive).

 08-11-2017 :
Intimation that Mr. Silas Xu, Founding Partner and Mr. Tushar Mallo, Partner of Ishana Capital, a newly formed long/short equity hedge fund based in Hong Kong, would be having a meeting with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Head- Strategy and Development, Mr. Vatsal Goyal, by 4.15 P.M. on Friday, November 10, 2017, at our office.

 16-09-2017 :
Intimation about con-call arranged by Edelweiss between Mr. Arnab Nandi, Portfolio Manager of Oxbow Capital and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, September 20, 2017.

 15-09-2017 :
Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi,General Manager-Finance and/or Mr. Vatsal Goyal, Head – Strategy & Development, at different timings on the 18th, 19th and 21st September, 2017, at our office.

 07-09-2017 :
Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, between 2.00 P.M.and 5.00 P.M. on Thursday, September 07, 2017, at our office.

 05-09-2017 :
Intimation about meeting of Mr. Rakesh Nayudu, Analyst- Healthcare, of Haitong Securities India Private Limited, and his team with Mr. Sachin Salvi, General Manager-Finance, by 10.00 A.M. on Friday, September 08, 2017, at our office.

 05-09-2017 :
Intimation about participation of Mr.Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Wednesday, September 06, 2017.

 18-08-2017 :
Intimation about change in the Board of Directors, i.e. appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the retiring director, who had expressed his intention not to seek reappointment.

 18-08-2017 :
Intimation about the post-quarterly results conference call scheduled to be held at 3.00 p.m. on Monday,21-08-2017.

 17-08-2017 :
An update of the 17th Annual General Meeting of the Company held on 12-08-2017 and the resolutions passed thereat.

 12-08-2017 :
Intimation about decisions taken at the Board Meeting held on August 12, 2017, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2017, as per IND-AS Standards.

 05-08-2017 :
Intimation about Board Meeting scheduled to be held on August 12, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter ended June 30, 2017.

 05-08-2017 : 
Intimation about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the director liable to retire at the ensuing AGM to be held on 12-08-2017, who has expressed his intention not to seek reappointment.

 22-07-2017 : 
Intimation about 17th Annual General Meeting convened to be held on 12-08-2017 at 10.30 A.M. , Book-Closure for payment of final dividend of Rs.5/- (on approval by shareholders), & e-voting facility available to the Shareholders.

 28-06-2017 :
Intimation about meeting of Mr. Naveen Baid, Senior Analyst and Mr. Avinash Nahata, Head-Fundamental Equity Desk, of Aditya Birla Money Ltd., and their team with our General Manager-Finance, Mr. Sachin Salvi, by 4.00 P.M. on Thursday, June 29, 2017, at our office.

 26-06-2017 :
Intimation about meeting of:
(i)Mr. Eric Jones, Portfolio Manager of Dragoneer Investment Group, U.S., with our Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 2.00 P.M. on Tuesday, June 27, 2017, at our office. The meeting is arranged by J M Financial Institutional Securities Ltd., Mumbai.
(ii)Mr. Vikas Gattani, CIO (based in Singapore) of Progress India Opportunities Fund, Mumbai, with our Vice-President (Operations), Dr. Caesar Sengupta and Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 9.30 A.M. on Wednesday, June 28, 2017, at our office.

 20-06-2017 :
Intimation about: Meeting of Mr. H. Sangameswar Iyer, V.P. Investments, Shubhkam Ventures, with our General Manager-Finance, Mr. Sachin Salvi, and Head – Strategy & Corporate Development, Mr. Vatsal Goyal, by 11.00 A.M. on Wednesday, June 21, 2017, at our office.

 17-06-2017 :
Intimation about: Meeting of Mr. Lukas Davies, Barca Capital USA, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head – Nueclear Operations, by 10.00 A.M. on Monday, June 19, 2017, at our office.

 14-06-2017:
Intimation about:
Meeting of one Group of Investor with our Chairman & Managing Director, Dr. A. Velumani, by 10.00 A.M., at our office on Thursday, June 15, 2017, arranged by New Horizon Fund; and
Meeting of the following investors with our Chairman & Managing Director, Dr. A. Velumani in the afternoon, arranged by Centrum at their office.

Click to view Fund Details and Representative meetings

 12-06-2017 :
Intimation that as the final dividend is subject to approval of members, the provision made therefor has been revised, resulting in increase of Rs.323.30 Million in Reserves & Surplus and decrease of similar amount from Short-term provisions. The revised Audited Financial Statements (both Stand-alone and Consolidated), are provided under Financial Statements.

 07-06-2017 :
Intimation about meetings of
Mr. Sudarshan Padmanabhan, Analyst, Sundaram Mutual Fund, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 10.00 A.M. on Thursday, June 08, 2017, at our office.
Mr. Thomas Mobille, Director/Senior Analyst, Limiar Capital Management, USA, with our General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 4.00 P.M. on Thursday, June 08, 2017, at our office.

 06-06-2017 :
Intimation about Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Nueclear Operations, participating at an investor conference organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident, BKC, on 7th June 2017, where the following fund managers will participate.

Click to view Details

 03-06-2017 :
Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place from 5th to 8th June 2017, during his visit to Hong Kong and Singapore.

Click to view Fund Details and Representative meetings

 22-05-2017 :
Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in an investor conference on 30th May, 2017 at Hotel Sofitel, BKC, Mumbai, an open session attended by global / domestic institutional investors / fund houses, etc., being arranged by Phillip Capital.

 10-05-2017 :
Intimation about conference call on 11-05-2017 about the Audited financial results for the quarter / whole year ended March 31, 2017.

 09-05-2017 :
Intimation about decisions taken at the Board Meeting held on May 09, 2017, about approval of the Audited Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2016-17 and recommending a final dividend of Rs.5/- per share, which is in addition to the interim dividend of Rs. 5/- already paid. With this, the total dividend for the year would be 100%.

 02-05-2017 :
Intimation about Board Meeting scheduled to be held on May 09, 2017 to approve audited financial statements (both Stand-alone and Consolidated) for FY 2016-17 and to consider granting of Stock Options to eligible employees for FY 2016-17.

 22-04-2017 :
Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place on 26th & 27th April 2017 during his visit to UK.

 22-04-2017 :
Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place on 26th & 27th April 2017 during his visit to UK.

Click to view Fund Details

 08-04-2017:
Intimation about meeting of Mr. Mahesh Natarajan of ICICI Securities and Mr. Shriraam Rathi, ISec Healthcare Research Analyst, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 9.30 a.m. at our office. Intimation about meeting of Analysts from Falcon Edge, Comgest, Goldman Sachs, PineBridge, East Bridge and a few other Investors, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 11.00 a.m., followed by a visit to our central Processing Laboratory at Navi Mumbai.

 05-04-2017 :
Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, 2017, by 10.00 A.M.

 24-03-2017 :
Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members wherever necessary:
(i) To reappoint Dr. A. Velumani as Managing Director & CEO for 3 years from 01-04-2017 on a token salary of Re. 1/- per month as chosen by him.
(ii) To reappoint Mr. A. Sundararaju as Executive Director & CFO for 3 years from 01-04-2017 on the same salary of Rs. 5 lakhs per month.
(iii) To acquire the trademark “Whaters” from Dr. A. Velumani, Chairman & Managing Director, who offered to assign the same to the Company for a token consideration of Re. 1/- and the trademark “Nueclear” to NHL, the wholly owned subsidiary, for a similar token consideration of Re. 1/-, and also waive the royalty due to him from both the companies for usage till now.
(iv) To give loan to NHL, the wholly owned subsidiary, at arm’s length basis, to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc. for setting up additional scanning centres.

 27-03-2017 :
Intimation about meeting of Mr. Abhishek Thepade, Fund Manager of DNB Nor, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Wednesday, March 29, 2017 by 10.00 A.M.

 21-03-2017 :
Intimation about meeting of Mr. Rahul Gupta, Investment Analyst, of Fidelity International, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Thursday, March 23, 2017 by 10.30 A.M.

 08-03-2017 :
Intimation about change in timing of Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 as 3.30 P.M., where some other analysts/investors might also join.

 07-03-2017 :
Intimation about a Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 by 11.00 A.M.

 23-02-2017 :
Intimation about meeting of Mr. Kahlil Randeria and his team from New Horizon Funds, India, with our Chairman & Managing Director, Dr. A. Velumani, by 05.00 P.M. on Wednesday, March 01, 2017, at our Corporate Office.

 22-02-2017 :
Intimation about meeting of Mr. Owens Huang, Asia Specialist & Co-Portfolio Manager from Dalton Investment, US, with our Vice-President (Operations), Dr. Caesar Sengupta, and General Manager-Finance, Mr. Sachin Salvi, at our Corporate Office, on Tuesday, February 28, 2017 by 03.00 P.M.

 22-02-2017 :
Intimation about meeting of Mr. Anup Maheshwari, CIO & Head of Equities of DSP Blackrock, and his team, with our Chairman & Managing Director, Dr. A. Velumani, at our Corporate Office, on Monday, February 27, 2017 by 12.00 Noon.

 16-02-2017 :
Intimation about meeting of Mr. Dushyant Sahani, Associate, of Samena Capital Investments Limited, Dubai, with our Vice President (Operations) Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, on Tuesday, February 21, 2017 by 03.00 PM and a likely meeting with our Chairman & Managing Director, Dr. A. Velumani too, subject to his availability.

 14-02-2017 :
Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General Manager-Finance, Mr.Sachin Salvi and the Marketing Team at our Corporate Office, on Wednesday, February 15, 2017 by 11.00 AM, and a likely visit to one of our franchisees thereafter.

 07-02-2017 :
Intimation about meeting of Mr. Balvinder Singh, Analyst from Canara HSBC, with our Vice-President (Operations), Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi, at our office by 5.00 PM on 09-02-2017.

 30-01-2017 :
Intimation about conference call on 31-01-2017 about the unaudited financial results for the quarter / nine-months ended December 31, 2016.

 24-01-2017 :
Intimation about meeting of Mr. Jack and Mr. Mohan of Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani at our office by 3.00 PM on 08-02-2017.

 19-01-2017 :
Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2016, and consider paying interim dividend if any.

 24-12-2016 :
Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr.Shaleen Kumar of UBS Securities India, at our office by 10.00 A.M. on 26-12-2016.

 19-12-2016 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Ms. Amisha Vora & Mr. Dilip Bhat, Joint Managing Directors, and Mr. Vishal & Mr. Shankar, Co-Heads-Equities, of Prabhudas Lilladher Pvt. Ltd. at our office by 3.00 P.M. on 22-12-2016.

 13-12-2016 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sandeep Kothari and Mr. Rahul Gupta, of Fidelity International at our office by 9.00 A.M. on 23-12-2016

 12-12-2016 :
Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in Spark Healthcare Conference 2016, in BKC, Mumbai on 13-12-2016.

 06-12-2016 :
Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr. Sarath Sathkumara, Managing Director, Taiyo Pacific Partners, USA, at our office, by 4.30 P.M. on 20-12-2016.

 06-12-2016 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Arindam Bhattacharjee, Partner & Portfolio Manager, Mr. Paul Ballantyne, Partner & Portfolio Manager, and Mr. Sebastian Peters, Portfolio Manager of Genesis Investment Management Ltd., UK, at our office, by 9.00 A.M. on 13-12-2016.

 01-12-2016 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sunil Asnani, Portfolio Manager of Matthews Asia of Matthews International Capital Management LLC, at our Office, at Navi Mumbai by 9.30 A.M.on 08-12-2016.

 01-12-2016 :
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Krishna Kumar, Portfolio Manager of Eastsprings Investments (Singapore) Ltd., a wholly owned subsidiary of Prudential Plc of UK, at Hotel Trident, BKC, Mumbai, by 8.00 A.M. on 07-12-2016.

 12-11-2016 :
Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani at the IDFC Annual Investor Conference at “The Taj Lands End”, Mumbai, on 16-11-2016 where he would talk briefly about the Company, its nature of business and growth, and would also meet various investors / analysts attending the conference.

 01-11-2016 :
Intimation about meeting of analysts from Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani on 02-11-2016 and visit of analysts from Phillip Capital (India) P. Ltd., to our Central Processing Laboratory at Navi Mumbai on 02-11-2016.

 24-10-2016 :
Intimation about conference call on 25-10-2016 about the unaudited financial results for the quarter / half-year ended September 30, 2016.

 24-10-2016 :
Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter / half-year ended September 30, 2016.

 28-09-2016 :
Intimation about meeting between a few investors / fund managers and our Chairman & Managing Director, Dr. A. Velumani, on Friday, September 30, 2016 at 9.00 A.M. at Hotel J W Marriott, Mumbai.

 27-09-2016:
Intimation about meeting between analysts from Ventura Capital with our General Manager-Finance, Mr. Sachin Salvi on Wednesday, September 28, 2016 at 11.00 A.M. at our office at Navi Mumbai.

 26-09-2016 :
Intimation about meeting between a few analysts / fund managers and our Chairman & Managing Director, Dr. A. Velumani on Tuesday, September 27, 2016 at 4.00 P.M. at our Office at Navi Mumbai.

 13-09-2016 :
Intimation about the 16th Annual General Meeting held on September 12, 2016.

 04-09-2016 :
Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani in a conference organised by Nomura group in UK where he had one-to-one meeting with representatives of six global fund managers.

 27-08-2016 :
Intimation about decision taken at the Board Meeting held on 27-08-2016 regarding sale of shares held by the Company in Thyrocare International Holding Co., Mauritius, to a relative of the Promoters.

 22-07-2016:
Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter ended June 30, 2016.

 15-07-2016:
Intimation about Board Meeting scheduled to be held on July 22, 2016 to approve unaudited financial results (Stand-alone and Consolidated), for the quarter ended June 30, 2016.

 23-06-2016:
Intimation about Meeting of a few analysts / fund managers with our Chairman & Managing Director at the Company’s Corporate Office at 10.00 a.m. on 24-06-2016.

 14-06-2016 :
Intimation about Conference call arranged by the Company on June 15, 2016 for Indian and Overseas Investors to discuss about the financial results of Quarter / Financial Year ended 31-03-2016.

 11-06-2016 :
Intimation about decisions taken at the Board Meeting held on June 11, 2016, about approval of the Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2015-16 and recommending a final dividend of Rs. 2.5 per share. This is in addition to two interim dividends of Rs. 3.75 each, totaling to Rs. 7.50 per share, already paid. With this, the total dividend for the year would be 100%.

 04-06-2016 :
Intimation about Board Meeting scheduled to be held on June 11, 2016 to approve financial statements (both Stand-alone and Consolidated), consider granting of Stock Options to eligible employees for FY 2015-16 and consider recommending final dividend if any.

 01-06-2016 :
Intimation about Participation by the Company’s Chairman & Managing Director, Dr. A. Velumani in an Investors Conference organized by M/s. Batlivala & Karani Securities India Pvt. Limited on June 03, 2016 at Hotel Trident, where the following Fund Managers will have a meeting with him.

Click to view Fund Details

 23-05-2016 :
Intimation about Plant visit by Analyst/Institutional Investor (Ambit Capital P. Ltd.) followed by one-to-one meeting on May 24, 2016.

 18-05-2016 :
Intimation about Plant visit by Analyst/Institutional Investor (Fidelity International) followed by one-to-one meeting on May 25, 2016.

Latest Press Releases/Advertisements :

 Advertisement – Announcement regarding Board Meeting to be held on February 09, 2019, to, inter alia, consider and approve unaudited financial results (Stand-alone and Consolidated) for the quarter / nine months ended 31-12-2018 and declaration of interim dividend, if any View here

 Advertisement – Unaudited financial statement – Stand alone & Consolidated – for quarter / half year ended September 30, 2018. View here

 Presentation – Unaudited Financial Results for the quarter / half year ended September 30, 2018. View here

 Press Release – Highlights of Unaudited Financial Results for the quarter / half year ended September 30, 2018. View here

Advertisement – Revised Notice of 18th Annual General Meeting, remote E-Voting information and book closure.
View here for English
View here for Marathi

 Presentation – Unaudited results of Quarter ended June 2018. View here

 Advertisement – Announcement regarding Board Meeting to be held on August 11, 2018, to, inter alia, consider and approve unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2018. View here

 Advertisement – Notice of 18th Annual General Meeting, remote E-Voting information and book closure.
View here for English
View here for Marathi

 Presentation – Audited results of Financial Year 2017-18. View here

 Advertisement – Audited financial statement – Stand alone & Consolidated for quarter / whole year ended March 31, 2018. View here

 Media Release – Highlights of Audited Results for the quarter / whole year ended March 31, 2018. View here

 Advertisement – Announcement regarding Board Meeting to be held on April 28, 2018, to approve Audited financial results (Stand-alone and Consolidated) for the quarter/year ended 31-03-2018, to consider recommending final dividend, if any,for 2017-18 and to consider granting stock options to employees for 2017-18. View here

 Advertisement – Investor Presentation on unaudited financial results for the quarter/nine months ended 31-12-2017. View here

 Advertisement – Extract of Unaudited Consolidated/Standalone Financial Results for the Quarter and Nine months ended 31 December 2017. View here

 Advertisement – Announcement regarding Board Meeting to be held on February 03, 2018, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2017. View here

 Press Release about Launch of Focus TB – The brand for Tuberculosis Testing Services through highly advanced technologies at an affordable cost View here

 Advertisement – Extract of Unaudited Consolidated/Standalone Financial Results for the Quarter and Six months ended 30 September,2017 View here

 Advertisement – Investor Presentation on unaudited financial results for the quarter/half year 30-09-2017 View here

 Advertisement – Media release on unaudited financial results for the quarter/half year 30-09-2017 View here

 Advertisement – Announcement regarding Board Meeting to be held on December 09, 2017 to approve unaudited financial results (Stand-alone and Consolidated) for the quarter/half year ended 30-09-2017 and to consider declaring interim dividend. View here

 Advertisement – Unaudited financial statements – Consolidated / Stand-alone for quarter ended June 30, 2017. View here

 Advertisement – Announcement regarding Board Meeting to be held on August 12, 2017, to approve unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2017. View here

 Advertisement – Intimation under Sec. 160 of the Companies Act, 2013 about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the retiring Director, who has expressed his intention not to seek reappointment. View here

 Advertisement – Notice of 17th Annual General Meeting, remote E-Voting information and book closure 
view here for English

 Advertisement – Notice of 17th Annual General Meeting, remote E-Voting information and book closure 
view here for Marathi

 Advertisement – Audited financial statements – Consolidated for quarter / financial year ended March 31, 2017. View here

 Presentation – Audited results of Financial Year 2016-17. View here

 Media Release – Highlights of Audited Results of financial year ended March 31, 2017. View here

 Advertisement – Announcement regarding Board Meeting to be held on May 09, 2017 for approval of financial statements for the year ended 31-03-2017. View here

 Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter/Nine months ended December 31, 2016. View here

 Advertisement – Announcement regarding Board Meeting to be held on January 28, 2017. View here

 Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter/Half Year ended September 30, 2016. View here

 Advertisement – Announcement regarding Board Meeting to be held on Oct 24th, 2016. View here

 Advertisement – Notice of 16th Annual General Meeting, remote E-Voting information and book closureView here for EnglishView here for Marathi

 

 Advertisement – Extract of Unaudited Consolidated Financial Results for the Quarter ended June 30, 2016. View here

 Advertisement – Announcement regarding Board Meeting to be held on July 22, 2016.

 Advertisement – Audited financial statement – Consolidated for quarter / financial year ended March 31, 2016.

 Advertisement – Announcement regarding Board Meeting to be held on June 11, 2016.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Corporate Governance

The Motto of Thyrocare Management is to provide Responsible Leadership and Effective Corporate Governance, and to maximize the enterprise value of the Company for the benefit of all stakeholders.

Composition of our Board of Directors and various Committees meets with the requirements enumerated in Companies Act, 2013 and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

COMPOSITION OF BOARD OF DIRECTORS

1. Dr. A. Velumani – CHAIRMAN & MANAGING DIRECTOR AND CEO.

2. Mr. A. Sundararaju – EXECUTIVE DIRECTOR & CFO.

3. Mr. Gopalkrishna Shivaram Hegde – INDEPENDENT DIRECTOR

4. Mr. Vishwas Kulkarni – INDEPENDENT DIRECTOR

5. Dr. Neetin Desai – INDEPENDENT DIRECTOR

6. Mr. N. Palanisamy – INDEPENDENT DIRECTOR

7. Miss. Amruta Velumani – NON-EXECUTIVE DIRECTOR

8. Dr. Indumati Gopinathan – NON-EXECUTIVE DIRECTOR

 

The Board of Directors has two Executive Directors and six Non-Executive Directors.

Independent Directors constitute one-half of the Board of Directors.

The Board has two woman directors.

COMPOSITION OF VARIOUS COMMITTEES OF BOARD OF DIRECTORS
CORPORATE GOVERNANCE POLICIES
DETAILS OF UNCLAIMED DIVIDEND

Shareholding Pattern

Know our Shareholding Pattern

Pattern for Website.pdf

Financial Statements

Access our latest quarterly earnings releases, annual reports and other information from the links available below.

Year

Apr – Jun

Jul – Sep

Oct – Dec

Jan – Mar

2018-19
2017-18
2016-17
Q4 |  Revised
2015-16

AGM Papers

Stock Information

Glossary

Accounting Period : The period of time over which financial result, i.e. profit or loss, of a business operation, is calculated.

Accrued expenses: An expense, which has been incurred but not yet paid for.

Amortisation : An accounting method, whereby an expenditure incurred or an income earned is accounted over a longer period of time instead of in the year in which the expenditure is incurred or income has accrued, depending upon the long-term impact of such expenditure or income.

Book value :Total assets minus total liabilities of a business. This is often expressed in the form of book value of share, which means the value of total assets minus total liabilities, divided by the total number of shares. This is also called net worth.

Break-even point : Refers to the point of equilibrium where the cost incurred and income earned in a business activity is the same and there is no profit or loss. Breakeven point is often expressed as the number of units that must be sold to produce revenues exactly equal to expenses. Sales above the breakeven point produce a profit; below cause a loss.

CAGR : This refers to the Compounded Annual Growth Rate, i.e.the mean annual growth of a business over a given period of time.

Cash flow : The statement showing the actual net cash generated or utilised through various activities of a business, showing the opening and closing cash balances.

Contingent liability:Expenditure that may have to be incurred only in the event of an incident happening; for example, in the case of a legal dispute, an expenditure or outgo may or may not be incurred depending upon whether the verdict goes against or in favour of the Company.

Current Asset :Cash and other forms of asset, which can be converted or which are expected to be converted into cash within a period of next 12 months.

Current Liabilities : Those liabilities which will fall due or which are expected to be paid within a period of next 12 months.

Depreciation : Estimated reduction in the value of an asset used in the business. This is arrived by dividing the value of the asset by the expected number of years of useful life of that asset. In other words, this is the proportion of the cost of an asset written off every year over a given period of time.

Dividend : Distribution of the post-tax profits of a business to the shareholders. Interim Dividend refers to the dividend paid in the middle of accounting period, and Final Dividend refers to the dividend declared after finalisation of accounts and ascertainment of the net profit during that period.

Earnings per share :A company’s net profit after taxes for an accounting period, divided by the average total number of shares outstanding during that period.

EBITDA : Earnings of a company before considering Interest costs, Tax expenses, Depreciation and Amortisation charges.

Financial year : An accounting period usually commencing from April 1st and ending on March 31st next year.

Fixed cost: a cost that does not change as the volume of production changes (in the short run.)

Intangible Asset: An asset, which is not tangible but which has a value of its own, such as trademark, copyright, patent, etc.

Goodwill: Normally, the notional value of an intangible asset, such as reputation, brand, loyalty of customers, etc.

Minority Interest : The share of the consolidated profit or loss of a company, which is attributable to that part of the non-controlling ownership in the subsidiary, which is different from that of the company concerned.

Non-Current Asset : All forms of assets other than current assets, i.e. those assets which cannot be converted or which are not expected to be converted into cash within the next 12 months.

Non-Current Liabilities : All those liabilities other than Current Liabilities, i.e. those liabilities which will not fall due or which are not expected to be paid within the next 12 months.

Prepaid expenses : Expenses relating to a future period already paid during an earlier accounting period.

Price-earnings (P/E) ratio : The ratio of the Earning-per-share to the market price of that share.

Retained earnings : Profits not distributed to shareholders as dividends, i.e. the accumulation of a company’s profits less any dividends paid out.

Risk : The possibility of loss or a negative impact.

Tangible Asset : Usually an asset that has physical characteristics, such as land, building, machinery, etc.

Trade payable : Amounts owed by the company to others for the goods supplied or services rendered by them to the Company.

Trade receivable : Amounts owed to the company by others for the goods supplied or services rendered by the Company to them.

Variable cost : A cost that varies in proportion to the increase or decrease in the volume of production.

Year-on-year:: The performance of a business operation in a particular year as compared with that of the previous year.

Investor Contacts

Thyrocare Technologies Limited
Corporate Identity No. L85110MH2000PLC123882

Registered Office:
D-37/1, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400 703

Corporate Office:
D-37/3, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400 703

Telephone No. (91)(22)2762 2762
Fax No. (91)(22)2768 2409
E-Mail: investor_relations@thyrocare.com
Website: www.thyrocare.com

Contact Details:
Company

All issues relating to Investors

investor_relations@thyrocare.com

Specific Grievances of Shareholders & Corporate Governance issues

Mr. Ramjee Dorai
Company Secretary & Compliance Officer
E-Mail: investor_relations@thyrocare.com

Financial Disclosures

Mr. Sachin Salvi
General Manager – Finance
E-Mail: investor_relations@thyrocare.com

Share Registrar / Transfer Agent

Link Intime India Pvt. Ltd
C-13, Pannalal Silk Mills Compound,
L.B.S.Marg, Bhandup (West),Mumbai – 400078.
E-Mail: rnt.helpdesk@linkintime.co.in
Phone: 022 – 2594 6970